| 08:50-09:00 | Opening Remark | 이병철 (대한뇌졸중학회 회장) |
| Stroke Pathophysiology | 좌장: 노재규(국군수도병원) 이광호(성균관의대) |
|
| 09:00-09:25 | Leptomeningeal Collaterals Are Associated with Modifiable Metabolic Risk Factors | 손성일(계명의대 신경과) |
| 09:25-09:50 | MRI Approach to Assess Collateral Flow in Acute Ischemic Stroke | 방오영(성균관의대 신경과) |
| 09:50-10:15 | Long-term Outcomes in Adult Moyamoya Disease | 조원상(서울의대 신경외과) |
| 10:15-10:40 | Cerebral Aneurysm Pathophysiology | 정근화(서울의대 신경과) |
| 10:40-10:55 | Coffee Break | |
| Plenary Session | 좌장: 정진상(성균관의대) | |
| 10:55-11:55 | Sex Differences on Stroke Risk and Quality of Life After Stroke | Cheryl D. Bushnell (Wake Forest Baptist Medical Center) |
| 11:55-12:15 | General Assembly | |
| Luncheon Symposium (Sponsored by Sanofi) | 좌장: 이병철(한림의대) 권순억(울산의대) |
|
| 12:15-12:40 | Dual Antiplatelet Therapy in Stroke Patients : Pros vs Cons | 이주헌(한림의대 신경과) |
| 12:40-13:05 | Is Aspirin Still The Best Option for Secondary Prevention of Stroke? | 차재관(동아의대 신경과) |
| 13:05-14:05 | Professor-Led Poster Tour | |
| New Era of Thrombolytic Treatment | 좌장: 윤병우(서울의대) 서대철(울산의대) |
|
| 14:05-14:30 | History of Clinical Trials of Intra-arterial Thrombolysis Before The New Devices | 조아현(가톨릭의대 신경과) |
| 14:30-14:55 | MRCLEAN, EXTEND IA, ESCAPE and SWIFT-PRIME | 송동범(연세의대 신경과) |
| 14:55-15:20 | Why Are The New Devices Successful? | 서우근(고려의대 신경과) |
| 15:20-15:45 | Next Big Issues in Thrombolysis | 이 준(영남의대 신경과) |
| 15:45-16:00 | Coffee Break | |
| Revelation of White Matter Disease | 좌장: 허지회(연세의대) 장대일(경희의대) |
|
| 16:00-16:25 | White Matter Disease: Leukoaraiosis vs. Microbleeds | 이승훈(서울의대 신경과) |
| 16:25-16:50 | Extensive Leukoaraiosis Is Associated with High Early Risk of Recurrence After Ischemic Stroke | 김경문(성균관의대 신경과) |
| 16:50-17:15 | Pulse Wave Velocity and White Matter Disease | 김진권(차의대 신경과) |
| 17:15-17:40 | Grading and Iinterpretation of White Matter Hyperintensities using Statistical Maps | 김동억(동국의대 신경과) |
| 17:40 | Closing Remark | 이병철(대한뇌졸중학회 회장) |
